인진쑥과 녹차 추출물 복합물인 SD1003F의 Helicobacter pylori 연관 기능성 위장장애 지원자에 대한 유효성 및 안전성 평가를 위한 무작위 배정, 이중 맹검, 위약대조 임상시험 = Randomized, Double-blind, Placebo-controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Artemisia and Green Tea Extract SD1003F in Volunteers with Helicobacter pylori-associated Gastric Discomfort

다국어 초록 (Multilingual Abstract)

Background/Aims: A previous study showed that dietary intervention with Artemisia and green tea extracts, i.e., SD1003F, relieved Helicobacter pylori-associated chronic atrophic gastritis in a mouse model. We continue the research through the current randomized double-blind clinical trial to evaluate the efficacy and safety of the intervention for H. pylori-associated gastric discomfort.
Materials and Methods: Forty-nine volunteers who tested positive for H. pylori infection received either placebo or SD1003F for 10 weeks and their functional dyspepsia-related quality of life (QOL) was evaluated. H. pylori infection using a urea breath test (UBT), measurement of pepsinogen level using GastroPanel. Adverse effects with biochemical changes were also evaluated.
Results: SD1003F administration significantly improved health related-QOL, including dietary intake, emotional stability, life pattern, and social factors relevant to gastric discomfort, in comparison to the control (P＜0.05). The mean UBT measurement significantly decreased in the SD1003F group (P＜0.05). In 2 of the 24 volunteers, SD1003F alone eradicated H. pylori infection, with significant improvements in endoscopic findings. GastroPanel analysis revealed significant improvements that reflect rejuvenation of gastric atrophy in the SD1003F group. No significant side effect was observed in any participant.
Conclusions: SD1003F (Artemisia and green tea extract), is a potential phytochemical to improve H. pylori-associated gastric discomfort.

참고문헌 (Reference)

1 Pathak CM, "Urea breath test for Helicobacter pylori detection: present status" 25 : 156-161, 2004

2 Kim MN, "The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication" 13 : 261-268, 2008

3 이수연, "The Korean Perspective of Helicobacter pylori Infection: Lessons from Japan Policy to Prevent Gastric Cancer" 대한암예방학회 18 (18): 107-112, 2013

4 박종민, "The Anti-inflammatory Effects of Acidic Polysaccharide from Artemisia capillaris on Helicobacter pylori Infection" 대한암예방학회 18 (18): 161-168, 2013

5 Bhat R, "Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors" 24 : 4162-4165, 2014

6 Kim JH, "Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea" 16 : 969-975, 2001

7 Lee SY, "Phytoceuticals: mighty but ignored weapons against Helicobacter pylori infection" 9 : 129-139, 2008

8 Park SH, "Non-microbial approach for Helicobacter pylori as faster track to prevent gastric cancer than simple eradication" 19 : 8986-8995, 2013

9 Pincock S, "Nobel prize winners Robin Warren and Barry Marshall" 366 : 1429-, 2005

10 Lee JH, "Inhibition of Helicobacter pylori adhesion to human gastric adenocarcinoma epithelial cells by acidic polysaccharides from Artemisia capillaris and Panax ginseng" 70 : 615-619, 2004

11 Oh TY, "Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract" 11 : 7450-7456, 2005

12 Kim JS, "In vivo gastric residence and gastroprotective effect of floating gastroretentive tablet of DA-9601, an extract of Artemisia asiatica, in beagle dogs" 10 : 1917-1925, 2016

13 Marshall DG, "Helicobacter pylori--a conundrum of genetic diversity" 144 : 2925-2939, 1998

14 Fujiki H, "Green tea: health benefits as cancer preventive for humans" 5 : 119-132, 2005

15 Yang XH, "Epigallocatechin-3-gallate attenuates renal damage by suppressing oxidative stress in diabetic db/db mice" 2016 : 2968462-, 2016

16 Li S, "Epigallocatechin gallate inhibits the HIV reverse transcription step" 21 : 239-243, 2011

17 Puram S, "Effect of gutgard in the management of Helicobacter pylori: a randomized double blind placebo controlled study" 2013 : 263805-, 2013

18 Zhang HS, "EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway" 90 : 747-754, 2012

19 Jeong M, "Dietary intervention of artemisia and green tea extracts to rejuvenate Helicobacter pylori-associated chronic atrophic gastritis and to prevent tumorigenesis" 21 : 40-59, 2016

20 Lee EH, "Development and validation of a functional dyspepsia-related quality of life (FD-QOL) scale in South Korea" 21 : 268-274, 2006

21 Cabrera C, "Beneficial effects of green tea--a review" 25 : 79-99, 2006

22 Lin HH, "Apoptotic effect of 3,4-dihydroxybenzoic acid on human gastric carcinoma cells involving JNK/p38 MAPK signaling activation" 120 : 2306-2316, 2007

23 Syrjanen KJ, "Accuracy of the GastroPanel test in the detection of atrophic gastritis" 27 : 102-104, 2015

24 Syrjanen K, "A panel of serum biomarkers ($GastroPanel^{(R)}$) in non-invasive diagnosis of atrophic gastritis. Systematic review and meta-analysis" 36 : 5133-5144, 2016

25 Asaka M, "A new approach for elimination of gastric cancer deaths in Japan" 132 : 1272-1276, 2013